The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 348:2045-2046 May 15, 2003 Number 20
NextNext

Marked Increase in Serum IgM during Treatment of Waldenström's Macroglobulinemia with Cladribine

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
To the Editor: We recently encountered two patients with Waldenström's macroglobulinemia1 who had a marked increase in the serum concentration of IgM M component during treatment with cladribine.2 Patient 1, a 78-year-old woman, reported shortness of breath and fatigue of two weeks' duration. Physical examination, a complete blood count, and serum chemical values were normal. An IgM-kappa M component was detected in serum; the total serum IgM concentration was 2580 mg per deciliter. A biopsy of a mass in the right side of the chest and right kidney revealed a B-cell lymphoma with plasma-cell differentiation. The bone marrow was also . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.